US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
イギリス
LSE
Orsero SpA (0YCG) 銘柄情報

Orsero SpA (0YCG)

8.65

0.00

(0.00%)

終了 7月11日 12:30AM

Orsero SpA (0YCG) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

8.65

( - )

買値

8.65

売値

8.65

出来高

1

平均取引量 (3 か月)

34,767 €

財務取引量

-

0.00 日の範囲 0.00

8.65 52 週間の範囲 8.65

時価総額

企業価値

386.206M

前日終値

8.65

始値

-

時刻

最終取引時間

VWAP

-

歳入

1.71B

純利益

28.24M

発行済株式数

16,848,643

浮動株比率 (%)

57.98%

機関投資家保有比率 (%)

18.03%

配当利回り

0.5 (3.29%)

PER

9.95

株価売上高倍率 (PSR)

0.16

1 株当たり利益 (EPS)

1.65

ベータ

0.5

Orsero S.p.A., together with its subsidiaries, imports and distributes fruits and vegetables in Europe, Latin America, and Central America. It operates through three segments: Distribution Sector, Shipping Sector, and Holding and Services Sector. The company offers exotic fruits, berries, kiwis, and... Orsero S.p.A., together with its subsidiaries, imports and distributes fruits and vegetables in Europe, Latin America, and Central America. It operates through three segments: Distribution Sector, Shipping Sector, and Holding and Services Sector. The company offers exotic fruits, berries, kiwis, and table grapes, as well as citrus fruits, stone fruit, and fresh-cuts; and avocados. It also engages in the maritime transport of bananas and pineapples under the F.lli Orsero and Simba brands. In addition, the company provides customs, information technology, and holding coordination services. Orsero S.p.A. was founded in 1940 and is based in Milan, Italy. 詳細を表示

セクター

Consumer Staples

業界

Consumer Staples Distribution & Retail

ウェブサイト

www.orserogroup.it

本社

Milan, Italy

設立

2026

Orsero SpA is listed in the Consumer Staples sector of the ロンドン証券取引所 with ticker 0YCG. The last closing price for Orsero was 8.65 €. Over the last year, Orsero shares have traded in a share price range of 8.65 € to 8.65 €.

Orsero currently has 16,848,643 shares in issue. The market capitalisation of Orsero is 145.74 € million. Orsero has a price to earnings ratio (PE ratio) of 9.95.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	8.65	8.65	8.65	1042	8.65	DE
52	0	0	8.65	8.65	8.65	457	8.65	DE
156	0	0	8.65	8.65	8.65	543	8.65	DE
260	0	0	8.65	8.65	8.65	407	8.65	DE

0YCG - Frequently Asked Questions (FAQ)

What is the current Orsero SpA share price?

The current share price of Orsero SpA is 8.65 €

How many Orsero SpA shares are in issue?

Orsero SpA has 16,848,643 shares in issue

What is the market cap of Orsero SpA?

The market capitalisation of Orsero SpA is EUR 145.74M

What is the 1 year trading range for Orsero SpA share price?

Orsero SpA has traded in the range of 8.65 € to 8.65 € during the past year

What is the PE ratio of Orsero SpA?

The price to earnings ratio of Orsero SpA is 9.95

What is the cash to sales ratio of Orsero SpA?

The cash to sales ratio of Orsero SpA is 0.16

What is the registered address of Orsero SpA?

The registered address for Orsero SpA is Via Vezza D’Oglio 7, Milan, Milan, 20139

What is the Orsero SpA website address?

The website address for Orsero SpA is www.orserogroup.it

Which industry sector does Orsero SpA operate in?

Orsero SpA operates in the Consumer Staples Distribution & Retail sector

chereb19

chereb19 5分前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

Kool Aid Man

Kool Aid Man 8分前

Q:--"Why would a Royal Qatari Sheikh worth multi-millions need an infamous, maxed out, toxic ticker littered with legal landmines in order to 'self fund' mining and drilling on at least 3 continents then split his profits with decades of old HIRU bag holders???"

A: He doesn't

shajandr

shajandr 11分前

Roofie the prison janitor.

jjjjjjjj

jjjjjjjj 19分前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3
IT IS DAMNED IF IT GOES UP, DAMNED IF IT GOES DOWN!
Which is it??? I repeat: IT IS DAMNED IF IT GOES UP. DAMNED IF IT GOES DOWN! Is today Mond

Kool Aid Man

Kool Aid Man 19分前

Has the bank said "no money was lost"? Then why are they suing?

rosemountbomber

rosemountbomber 40分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 42分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 51分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 1時間前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 1時間前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 1時間前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 1時間前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 1時間前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Genz2 1時間前

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 1時間前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 2時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 2時間前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 2時間前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Agnc Investment

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。